Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Impact of LCL161 on gene expression in human TAC T cells stimulated with antigen-coated microbeads

ABSTRACT: Impact of LCL161 on gene expression in human TAC T cells stimulated with antigen-coated microbeads

PROVIDER: PRJNA947625 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Impact of LCL161 on gene expression in human TAC T cells stimulated with antigen-coated microbeads

Project description:SMAC mimetics such as LCL161 are a novel class of anti-cancer drug that have been shown to induce costimulation in human T cells and augment anti-tumor capabilities. We investigated what impacts LCL161 has on gene expression in engineered anti-BCMA TAC T cells. TAC T cells were stimulated with BCMA-coated microbeads to deliver controlled antigenic signal alone.

2023-04-04 | GSE227986 | GEO

Comparative analysis of T cell receptor and chimeric antigen receptor signaling in primary CD8+ T cells

Project description:Chimeric antigen receptor-modified (CAR) T cell therapy targeting highly expressed lineage antigens is effective for B cell malignancies. Achieving durable efficacy for hematological malignancies and extending this therapeutic approach to solid tumors will require T cell recognition and elimination of tumor cells that may express lower levels of the CAR target antigen. Realizing this goal is challenging because current approaches to CAR design are largely empiric and detailed information on CAR signaling is only beginning to emerge. Synthetic CARs typically require hundreds of molecules on the target cell to initiate signaling, whereas natural T cell receptors (TCRs) can recognize less than ten peptide-MHC (pMHC) antigen complexes. We reasoned that in depth comparison of TCR and CAR stimulation-induced signaling events in primary T cells might guide rationale adaptations to CAR design that would improve antigen sensitivity. Bi-specific T cells possessing an endogenous TCR and exogenous CAR of defined specificity were formulated from healthy HLA-B8+ Epstein-Barr virus-seropositive donors. Bi-specific T cells were stimulated with magnetic microbeads coated with recombinant TCR or CAR antigen for 10, 45, or 90 minutes. Some bi-specific T cells were also left unstimulated and harvested at each timepoint to serve as controls. Altogether, 9 unique conditions were tested in an experiment and three independent experiments were performed.

2021-05-20 | PXD013734 | Pride

Expression Profiling of Heart (NH, TAC and TAC-R)

Project description:Transcriptome analysis of RNA samples from whole heart Transverse aortic constriction (TAC) is a well-established method for studying the pathomechanisms of heart failure in animal models of cardiac hypertrophy. A number of studies have shown that the treatment of heart failure in this animal model of cardiac hypertrophy suggests that hypertrophy and fibrosis may be reversible. However, since TAC-release protocols that improve hemodynamics by releasing physical stenosis remain undefined, the histological characteristics and molecular biological regulatory mechanisms of the reversibility of cardiac hypertrophy and fibrosis are unknown. Therefore, this study aimed to establish a TAC release model and investigate the reversibility and plasticity mechanisms of myocardial hypertrophy, fibrosis, and angiogenesis. Four weeks post-TAC surgery, TAC release was conducted by cutting the aortic stenosis sutures. The TAC group exhibited severe myocardial hypertrophy, fibrosis, and increased angiogenesis, along with diastolic dysfunction. Conversely, the TAC-release group showed reduced hypertrophy and fibrosis, and improved diastolic function. Gene expression analysis highlighted Regulator of Calcineurin 1 as a key player in cardiac function and histological changes post-TAC release. Rcan1 knockdown exacerbated myocardial hypertrophy and fibrosis in the TAC-release group. This study sheds light on the functional, structural, and histological changes in the heart induced by TAC release and elucidates some of its regulatory mechanisms.

2024-07-09 | GSE270186 | GEO

TAC metagenome

Project description:TAC metagenome Metagenome

| PRJNA687069 | ENA

ERCC TAC-seq

Project description:ERCC TAC-seq

| PRJNA428505 | ENA

Trisomy-TAC-seq

Project description:Trisomy-TAC-seq

| PRJNA431465 | ENA

Expression Profiling of Heart (NH, TAC and TAC-R)

Project description:Expression Profiling of Heart (NH, TAC and TAC-R)

| PRJNA1125390 | ENA

Coated/Uncoated Tobacco Seeds

Project description:Coated/Uncoated Tobacco Seeds

| PRJEB35804 | ENA

Transcription profiling of ovine keratinocytes stimulated with Psoroptes ovis mite antigen

Project description:Comparative expression profiles between unstimulated ovine keratinocytes and keratinocytes stimulated with whole mite antigen and whole mite wash in vitro, over a time course of 1, to 48 hours, using the RIGUA custom array (Watkins et al., 2008) and real-time RT-PCR

2009-07-01 | E-TABM-592 | biostudies-arrayexpress

Trisomy-TAC-seq II

Project description:Trisomy-TAC-seq II

| PRJNA498711 | ENA